Anti-allergic properties of pirquinozol (SQ 13,847) an orally effective agent. Evaluation in an anti-IgE-induced pulmonary function model in rats.
D000818:Animals; D001986:Bronchial Spasm / Q000188:drug therapy / Q000276:immunology; D006967:Hypersensitivity / Q000188:drug therapy*; D007073:Immunoglobulin E / Q000276:immunology; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects; D010366:Peak Expiratory Flow Rate; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D012129:Respiratory Function Tests; D012130:Respiratory Hypersensitivity / Q000188:drug therapy; D013997:Time Factors
D011799:Quinazolines; D007073:Immunoglobulin E; C028173:pirquinozol